Ref. References
1 An open-label pilot study to evaluate the safety and efficacy of topically applied pimecrolimus cream for the treatment of steroid-induced rosacea
15th Congr Eur Acad Dermatol Venereol (EADV) (Oct 4 2006 , Rhodes) 2006:Abst PO41.12.
Chu, C.-Y.
2 Clinical trial to evaluate the efficacy and safety of sodium bemiparin for treating ulcers in diabetic foot (NCT00448903)
ClinicalTrials.gov Web Site 2007
3 Treatment of severe atopic dermatitis with mycophenolate mofetil: 12-week open-label trial
15th Congr Eur Acad Dermatol Venereol (EADV) (Oct 4 2006 , Rhodes) 2006:Abst PO02.23.
Farnaghy, F., Seiraphy, H., Ehsani, A.H., Qandi, N.
4 Etanercept as a treatment for severe, treatment resistant psoriasis: A prospective open study
15th Congr Eur Acad Dermatol Venereol (EADV) (Oct 4 2006 , Rhodes) 2006:Abst PO35.113.
Perera, G.K., Jackson, K., Groves, R.W., Smith, C.H., Barker, J.N.W.N.
5 ISA247: Continued safety and efficacy after 60 weeks of continuous therapy in plaque psoriasis by SGA
16th Congr Eur Acad Dermatol Venereol (EADV) (May 16 2007 , Vienna) 2007:Abst P206.
Papp, K., Rosoph, L., Wasel, N., et al.
6 ISA247: Low rates of psoriatic flare or recurrence of disease after discontinuation of therapy
16th Congr Eur Acad Dermatol Venereol (EADV) (May 16 2007 , Vienna) 2007:Abst P207.
Tomi, Z., Poulin, Y., Carey, W., et al.
7 Safety profile of rupatadine in the treatment of chronic urticaria
16th Congr Eur Acad Dermatol Venereol (EADV) (May 16 2007 , Vienna) 2007:Abst P1354.
Giménez-Arnau, A., Malbran, A., Poop, G., Benea, V., Medina, I., Garcia, O., Donado, E.
8 Effective treatment of generalized pustular psoriasis by infliximab
15th Congr Eur Acad Dermatol Venereol (EADV) (Oct 4 2006 , Rhodes) 2006:Abst PO35.49.
Harvima, R.J., Sihvonen, T., Harvima, I.T.
9 Improvements in psoriasis disease severity control, and pruritus with adalimumab versus methotrexate and versus placebo in patients with moderate to severe chronic plaque psoriasis: Results of the CHAMPION trial
16th Congr Eur Acad Dermatol Venereol (EADV) (May 16 2007 , Vienna) 2007:Abst P1153.
Van de Kerkhof, P., Saurat, J., Ortonne, J., Stingl, G., Mcllraith, M.
10 Improvement in dermatology-specific quality of life with adalimumab treatment: Results from CHAMPION
16th Congr Eur Acad Dermatol Venereol (EADV) (May 16 2007 , Vienna) 2007:Abst P1147.
Langley, R.G., Saurat, J., Van de Kerkhof, P., Mrowietz, U., Okun, M.
11 Improvement in quality of life with adalimumab treatment as measured by EQ-5D: Results from CHAMPION
16th Congr Eur Acad Dermatol Venereol (EADV) (May 16 2007 , Vienna) 2007:Abst P1124.
Mrowietz, U., Van der Kerkhof, P., Papp, K., Saurat, J., Mcllraith, M.
12 Adalimumab efficacy and safety in patients with moderate to severe psoriasis: Results from the first 16 weeks of REVEAL
16th Congr Eur Acad Dermatol Venereol (EADV) (May 16 2007 , Vienna) 2007:Abst P1154.
Menter, A., Papp, K., Leonardi, C., Okun, M.
13 PASI 100 is associated with better dermatology-specific patient reported outcomes compared with PASI 75-99 in adalimumab-treated patients with psoriatic arthritis: Subanalysis of ADEPT
16th Congr Eur Acad Dermatol Venereol (EADV) (May 16 2007 , Vienna) 2007:Abst P1107.
Gladman, D., Mease, P., Ritchlin, C., Okun, M.
14 Adalimumab clinical trial safety in multiple indications and reduced mortality in rheumatoid arthritis
16th Congr Eur Acad Dermatol Venereol (EADV) (May 16 2007 , Vienna) 2007:Abst P1111.
Burmester, G., Mease, P., Dijkmans, B., Gordon, K., Lovell, D., Kent, J., Pangan, A.
15 Management of seborrheic dermatitis with 2% polyphenone (-)EGCg hydrophilic cream. A placebo-controlled, double-blind study
16th Congr Eur Acad Dermatol Venereol (EADV) (May 16 2007 , Vienna) 2007:Abst P264.
Syed, T., Wong, W.H.W., Benipoor, S., Ahmad, S.A., Govil, V., Aly, R.
16 Management of papulopustular rosacea with 2% green tea extract (-)EGCg hydrophilic cream. A placebo-controlled, double-blind study
16th Congr Eur Acad Dermatol Venereol (EADV) (May 16 2007 , Vienna) 2007:Abst P3.
Syed, T., Wong, W.H.W., Govil, V., Aly, R., Ahmad, S.A.
17 Multicenter clinical study to examine the efficacy and safety of zarzenda in patients with hand eczema (NCT00488241)
ClinicalTrials.gov Web Site 2007
18 Immunohistochemical changes in lesional tissue and impact on systemic immune markers following CNTO 1275 treatment in patients with psoriasis
J Invest Dermatol 2007, 127 (Suppl. 1):Abst 719.
Reddy, M., Torres, G., McCormick, T., Marano, C., Cooper, K., Yeilding, N., Hsu, M., Pendley, C., Prabhakar, U., et al.
19 Review of over 17 000 patient-years safety experience with efalizumab in patients with psoriasis
16th Congr Eur Acad Dermatol Venereol (EADV) (May 16 2007 , Vienna) 2007:Abst P1105.
Kragballe, K., Curtin, F.
20 Topical pimecrolimus in vitiligo - A preliminary study
Br J Dermatol 2007, 157 (Suppl. 1):Abst P-97.
Kanwar, A.J.
21 A phase 1, randomized, double-blind, placebo-controlled, dose-escalation, multicenter study to evaluate the safety and tolerability of single-dose for MEDI-545, (CP145) (NCT00472758)
ClinicalTrials.gov Web Site 2007
22 Complete response of deep neutrophilic dermatosis associated with myelodysplastic syndrome to 5-azacytidine
Br J Dermatol 2007, 156 (5):1039.
Raj, K., Ho, A., Creamer, J.D., du Vivier, A.W., Salisbury, J.R., Mufti, G.J.
23 Systemic and topical treatments for rash secondary to erlotinib in lung cancer (LUTRAERL) (NCT00473083)
ClinicalTrials.gov Web Site 2007
24 Treatment of erythema multiforme major with thalidomide: A report of two cases
Br J Dermatol 2007, 157 (Suppl. 1):Abst P-102.
Leitch, C., Jury, C.
25 Pain control in pyoderma gangrenosum using locally applied morphine
Br J Dermatol 2007, 157 (Suppl. 1):Abst P-96.
Barker, S., Duffill, M.
26 Epigallocatechin-galate infused cream has anti-angiogenic effects in rosacea
J Invest Dermatol 2007, 127 (Suppl. 1):Abst 23.
Santo Domingo, D., Camouse, M., Miller, J., Hsia, A.H., Ward, N.L., Matsui, M., Maes, D., Cooper, K.D., Baron, E.D.
27 A randomized controlled trial comparing pimecrolimus cream 1% and vehicle in patients with head & neck atopic dermatitis who are intolerant of, or dependent on topical corticosteroids: Quality of life outcomes
J Invest Dermatol 2007, 127 (Suppl. 1):Abst 326.
Murrell, D.F., Ho, V.C., Glendenning, A., Paul, C.F.
28 Clobetasol nail lacquer: A safe, effective and cosmetically acceptable treatment for nail psoriasis
Br J Dermatol 2007, 157 (Suppl. 1):Abst P-72.
Narang, T., Dogra, S., Kaur, I., Katare, O.P., Bhatia, A.
29 Intravenous immunoglobulin for the treatment of severe, recalcitrant atopic eczema in the elderly
Br J Dermatol 2007, 157 (Suppl. 1):Abst P-110.
Fallon, J., Murphy, G.M.
30 Phase I clinical trial underway for Welichem Biotech
Welichem Biotech Press Release 2007
31 Cytos Biotechnology reports results from phase IIa study with CYT003-QbG10 in patients suffering from atopic dermatitis
Cytos Biotechnology Press Release 2007
32 A randomized, placebo-controlled trial of rosiglitazone for HIV-related lipoatrophy
J Infect Dis 2007, 195 (12):1754.
Cavalcanti, R.B., Raboud, J., Shen, S., Kain, K.C., Cheung, A., Walmsley, S.
33 A retrospective study to asses oral versus topical psoralen ultraviolet A photochemotherapy for the treatment of hand and foot eczema
Br J Dermatol 2007, 157 (Suppl. 1):Abst PD-13.
Mitra, A., Yung, A., Turner, D., Elliot, F., Goulden, V.
34 A study of the safety and efficacy of CNTO 1275 in subjects with severe plaque-type psoriasis (NCT00320216)
ClinicalTrials.gov Web Site 2007
35 Dose-ranging efficacy study of topical NEOSH101 to treat male pattern hair loss (NCT00471510)
ClinicalTrials.gov Web Site 2007
36 A preliminary study on the efficacy of pimecrolimus 1% cream in seborrheic dermatitis of the external auditory meatus
15th Congr Eur Acad Dermatol Venereol (EADV) (Oct 4 2006 , Rhodes) 2006:Abst PO01.32.
Erkek, E., Kilic, R., Datli, F., Tuncez, F., Emir, H.
37 A study of the safety and efficacy of CNTO 1275 in patients with severe plaque-type psoriasis (NCT00267969)
ClinicalTrials.gov Web Site 2007
38 A pediatric longitudinal evaluation to assess the long-term safety of protopic for the treatment of atopic dermatitis (APPLES) (NCT00475605)
ClinicalTrials.gov Web Site 2007
39 Finasteride treatment of premature androgenetic alopecia
Endocr Abstr 2007, 14:Abst P444.
Duskova, M., Starka, L., Hill, M., Cermakova, I.
40 Successful treatment of recalcitrant pyoderma gangrenosum with raptiva
16th Congr Eur Acad Dermatol Venereol (EADV) (May 16 2007 , Vienna) 2007:Abst P1136.
Gulliver, W.
41 A randomized, controlled trial of pimecrolimus cream 1% in children with head and neck atopic dermatitis and intolerant of, or dependent on topical corticosteroids
16th Congr Eur Acad Dermatol Venereol (EADV) (May 16 2007 , Vienna) 2007:Abst P1565.
Hoeger, P., Lee, K.-H., Jautova, J., Wohlrab, J., Guettner, A., Mizutani, G.
42 CollaGenex Pharmaceuticals announces highly positive results of phase 2 dose-finding trial of Col-118 for the treatment of erythema
CollaGenex Pharmaceuticals Press Release 2007
43 Treatment of moderate to severe psoriasis with efalizumab: A six month follow up
16th Congr Eur Acad Dermatol Venereol (EADV) (May 16 2007 , Vienna) 2007:Abst P1052.
Solovan, C.S., Radivoi, D., Ciolan, M.
44 Botulinum toxin-A therapy for plantar hyperhidrosis - a four-year experience in Greece
16th Congr Eur Acad Dermatol Venereol (EADV) (May 16 2007 , Vienna) 2007:Abst P1293.
Kontochristopoulos, G., Agiasofitou, E., Gregoriou, S., Liakou, A., Nikolakis, G., Katsambas, A.
45 Oral fluticasone proprionate for the treatment of symptomatic esophageal Lichen planus: A case series
Gastroenterology 2007, 132 (4, Suppl. 2):Abst S1975.
Grover, S.C., Shin, J., Saravanan, R., Cho, S., Kamalaporn, P., May, G.R., Kandel, G., Kortan, P.P., Marcon, N.
46 Efficacy of 6-month oral mycophenolate sodium therapy in resistant oral lichen planus
16th Congr Eur Acad Dermatol Venereol (EADV) (May 16 2007 , Vienna) 2007:Abst P1296.
Bulbul, B.E., Erdem, H., Cikman, T.S., Tunali, S.
47 Inefficiency of tranexamic acid in the treatment of chronic idiopathic urticaria
26th Congr Eur Acad Allergol Clin Immunol (EAACI) (June 9 2007 , Göteborg) 2007:Abst 853.
Ktiouet-Abassi, S., Caboni, S., Nicolas, J.-F., Berard, F., Bouillet, L., Gunera-Saad, N.


[ Close ]